Literature DB >> 31993941

Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression.

Hyungjin Rhee1, Taek Chung2,3, Jeong Eun Yoo2, Ji Hae Nahm2, Ha Young Woo2, Gi Hong Choi4, Dai Hoon Han4, Young Nyun Park5,6.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is subclassified into five gross types, namely, vaguely nodular (VN), single nodular (SN), single nodular with extranodular growth (SNEG), confluent multinodular (CM), and infiltrative (INF) type. However, the pathological background underlying differences in biological behavior of different gross types of HCC remains unclear.
METHODS: The histopathological features, clinical outcomes of HCC gross types, and their relationships with stemness-related marker status and fibrotic/hypoxic tumor microenvironment (TME) were evaluated in 266 resected HCCs. The stemness-related markers (CD24, CD44, CD133, SALL4, YAP1, K19 and EpCAM), fibrous tumor stroma (αSMA), and hypoxia (CAIX) were evaluated with immunohistochemistry.
RESULTS: Poorer differentiation, reduced capsule formation, higher microvascular invasion, larger tumor size and larger area of necrosis were observed in order of VN-SN-SNEG-CM-INF type (p = 0.005 for all, linear-by-linear association). The expression of summed stemness-related markers and hypoxic/fibrotic TME showed an increasing trend in order of VN-SN-SNEG-CM-INF type (p < 0.005), and their expression well correlated with each other. INF type was found only in HCCs with hypoxic/fibrotic TME or high expression of stemness-related markers. CAIX expression and tumor necrosis ≥ 30% were independent prognostic markers for disease-specific survival. Early recurrence-free survival showed a significant difference based on gross types, revealing best outcome with VN type and worst outcome with INF type.
CONCLUSION: The marker expression of stemness-related and hypoxic/fibrotic TME of HCC showed an increasing trend in order of VN-SN-SNEG-CM-INF gross types, and their cross-talk may be involved in the determination of various gross-morphological features and their distinct biological behavior.

Entities:  

Keywords:  Early recurrence; Fibrous tumor stroma; Gross morphology; Hepatocellular carcinoma; Hypoxia; Immunohistochemistry; Microvascular invasion; Stemness; Tumor microenvironment; Tumor necrosis

Mesh:

Substances:

Year:  2020        PMID: 31993941     DOI: 10.1007/s12072-020-10012-6

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  26 in total

1.  Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.

Authors:  Xiang H-F Zhang; Xin Jin; Srinivas Malladi; Yilong Zou; Yong H Wen; Edi Brogi; Marcel Smid; John A Foekens; Joan Massagué
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

2.  Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy.

Authors:  A M Hui; T Takayama; K Sano; K Kubota; M Akahane; K Ohtomo; M Makuuchi
Journal:  J Hepatol       Date:  2000-12       Impact factor: 25.083

3.  Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.

Authors:  Haeryoung Kim; Gi Hong Choi; Deuk Chae Na; Ei Young Ahn; Gwang Il Kim; Jae Eun Lee; Jai Young Cho; Jeong Eun Yoo; Jin Sub Choi; Young Nyun Park
Journal:  Hepatology       Date:  2011-11       Impact factor: 17.425

4.  The role of macroscopic classification in nodular-type hepatocellular carcinoma.

Authors:  M Shimada; T Rikimaru; T Hamatsu; Y Yamashita; T Terashi; K Taguchi; S Tanaka; K Shirabe; K Sugimachi
Journal:  Am J Surg       Date:  2001-08       Impact factor: 2.565

5.  A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition.

Authors:  Jae Yeon Seok; Deuk Chae Na; Hyun Goo Woo; Massimo Roncalli; So Mee Kwon; Jeong Eun Yoo; Ei Yong Ahn; Gwang Il Kim; Jin-Sub Choi; Young Bae Kim; Young Nyun Park
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

Review 6.  Cancer-associated fibroblasts in hepatocellular carcinoma.

Authors:  Norio Kubo; Kenichiro Araki; Hiroyuki Kuwano; Ken Shirabe
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

7.  Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling.

Authors:  Eunice Yuen Ting Lau; Jessica Lo; Bowie Yik Ling Cheng; Mark Kin Fai Ma; Joyce Man Fong Lee; Johnson Kai Yu Ng; Stella Chai; Chi Ho Lin; Suk Ying Tsang; Stephanie Ma; Irene Oi Lin Ng; Terence Kin Wah Lee
Journal:  Cell Rep       Date:  2016-04-28       Impact factor: 9.423

8.  A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection.

Authors:  Jean-Charles Nault; Aurélien De Reyniès; Augusto Villanueva; Julien Calderaro; Sandra Rebouissou; Gabrielle Couchy; Thomas Decaens; Dominique Franco; Sandrine Imbeaud; Francis Rousseau; Daniel Azoulay; Jean Saric; Jean-Frédéric Blanc; Charles Balabaud; Paulette Bioulac-Sage; Alexis Laurent; Pierre Laurent-Puig; Josep M Llovet; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2013-04-06       Impact factor: 22.682

9.  Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization.

Authors:  Hyungjin Rhee; Ji Hae Nahm; Haeryoung Kim; Gi Hong Choi; Jeong Eun Yoo; Hye Sun Lee; Myoung Ju Koh; Young Nyun Park
Journal:  Mod Pathol       Date:  2016-06-17       Impact factor: 7.842

Review 10.  The role of hypoxia inducible factor-1 in hepatocellular carcinoma.

Authors:  Dongjun Luo; Zhongxia Wang; Junyi Wu; Chunping Jiang; Junhua Wu
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

View more
  7 in total

Review 1.  Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.

Authors:  Hyungjin Rhee; Haeryoung Kim; Young Nyun Park
Journal:  Liver Cancer       Date:  2020-10-23       Impact factor: 11.740

2.  Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study.

Authors:  Hong Wei; Hanyu Jiang; Yun Qin; Yuanan Wu; Jeong Min Lee; Fang Yuan; Tianying Zheng; Ting Duan; Zhen Zhang; Yali Qu; Jie Chen; Yuntian Chen; Zheng Ye; Shan Yao; Lin Zhang; Ting Yang; Bin Song
Journal:  Eur Radiol       Date:  2022-05-13       Impact factor: 5.315

3.  Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma.

Authors:  Yi-Hong Ling; Jie-Wei Chen; Shi-Hong Wen; Chao-Yun Huang; Peng Li; Liang-He Lu; Jie Mei; Shao-Hua Li; Wei Wei; Mu-Yan Cai; Rong-Ping Guo
Journal:  BMC Cancer       Date:  2020-06-29       Impact factor: 4.430

4.  The novel interplay between CD44 standard isoform and the caspase-1/IL1B pathway to induce hepatocellular carcinoma progression.

Authors:  Jun Li; Yongwei Zhang; Ran Ruan; Wei He; Yeben Qian
Journal:  Cell Death Dis       Date:  2020-11-09       Impact factor: 8.469

5.  Single Large Nodule (>5 cm) Prognosis in Hepatocellular Carcinoma: Kinship with Barcelona Clinic Liver Cancer (BCLC) Stage A or B?

Authors:  Li Wan; Ding-Hui Dong; Xiao-Ning Wu; Hong-Fan Ding; Qiang Lu; Yong Tian; Xu-Feng Zhang; Wenzhi Li
Journal:  Med Sci Monit       Date:  2020-10-16

6.  Predicting microvascular invasion in hepatocellular carcinoma: A dual-institution study on gadoxetate disodium-enhanced MRI.

Authors:  Hanyu Jiang; Jingwei Wei; Fangfang Fu; Hong Wei; Yun Qin; Ting Duan; Weixia Chen; Kunlin Xie; Jeong Min Lee; Mustafa R Bashir; Meiyun Wang; Bin Song; Jie Tian
Journal:  Liver Int       Date:  2022-03-11       Impact factor: 8.754

7.  Clinical features and prognostic factors in patients with microvascular infiltration of hepatocellular carcinoma: Development and validation of a nomogram and risk stratification based on the SEER database.

Authors:  Dashuai Yang; Mingqiang Zhu; Xiangyun Xiong; Yang Su; Fangrui Zhao; Yong Hu; Guo Zhang; Junpeng Pei; Youming Ding
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.